The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $58.04

Today's change+0.84 +1.47%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.
 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $58.04

Today's change+0.84 +1.47%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

PAREXEL International Corp up (U.S.)$0.84

PAREXEL International Corp closed up Wednesday by (U.S.)$0.84 or 1.47% to (U.S.)$58.04. Over the last five days, shares have gained 2.65% and 28.46% year to date. Shares have outperformed the S&P 500 by 25.87% during the last year.

Key company metrics

  • Open(U.S.) $57.49
  • Previous close(U.S.) $57.20
  • High(U.S.) $58.16
  • Low(U.S.) $57.00
  • Bid / Ask-- / --
  • YTD % change+28.46%
  • Volume346,346
  • Average volume (10-day)497,042
  • Average volume (1-month)942,056
  • Average volume (3-month)733,529
  • 52-week range(U.S.) $38.65 to (U.S.) $64.72
  • Beta0.96
  • Trailing P/E23.47×
  • P/E 1 year forward21.61×
  • Forward PEG1.26×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.47
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.07%

Based on its net profit margin of 6.07%, PAREXEL International Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue574585578574
Total other revenue--------
Total revenue574585578574
Gross profit174185171163
Total cost of revenue400400407411
Total operating expense520526526528
Selling / general / administrative991039796
Research & development--------
Depreciation / amortization20212120
Interest expense (income), net operating--------
Unusual expense (income)--000
Other operating expenses, total--------
Operating income54595247
Interest income (expense), net non-operating-2-2-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax55565043
Income after tax37403528
Income tax, total18161515
Net income37403528
Total adjustments to net income--------
Net income before extra. items37403528
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items37403528
Inc. avail. to common incl. extra. items37403528
Diluted net income38403528
Dilution adjustment1--0--
Diluted weighted average shares56575857
Diluted EPS excluding extraordinary itemsvalue per share0.680.700.600.49
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.680.690.600.49